Genentech's Anderson to succeed O'Day at Roche

Genentech Inc. CEO Bill Anderson will succeed Daniel O’Day as the CEO of the pharmaceuticals division of Roche (SIX:ROG; OTCQX:RHHBY) on Jan. 1. O'Day is leaving Roche to head Gilead Sciences Inc. (NASDAQ:GILD) as chairman and CEO on March 1 (see "Roche's O'Day to Lead Gilead").

Roche spokesperson Nicolas Dunant told BioCentury it expects to find a new Genentech CEO to succeed Anderson soon...